London to Host Pioneering Global Forum on Cell and Gene Therapy Innovations

Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London

In an exciting development for the field of medicine, London is set to become the focal point for cell and gene therapy (CGT) this November. The upcoming GenScript Biotech Global Forum, scheduled for November 20, 2025, is poised to gather some of the most prominent figures in the sector, including Nobel Laureate researchers, innovative biotech leaders, and influential investors. The theme for the forum, "THE NEXT ERA OF CGT IS HERE," will address how these advancements can have sustainable real-world impacts on patient care.

The Promise of Cell and Gene Therapy

Cell and gene therapies represent a significant leap in modern medicine. They are not just theoretical concepts; they are transforming the landscape of healthcare by enabling researchers to translate discoveries from the lab into tangible clinical applications. This has led to an impressive surge in breakthroughs fueled by scientific innovation and growing global investments. From genome editing technologies to advanced cell therapy platforms, CGT is quickly evolving into one of the most promising fields within life sciences, replete with potential for the treatment of previously untreatable diseases.

Keynote Speakers Set to Inspire

The GenScript Biotech Global Forum will feature high-profile keynote addresses from leaders in the field. Dr. Craig Mello, a Nobel Laureate and co-director of the RNA Therapeutics Institute at the University of Massachusetts Medical School, will discuss the evolution of RNA interference (RNAi) and its transformative effects on genetic medicine. His talk, titled "RNAi: A Molecular Spark in an Information Inferno," will reflect on the relationship between foundational scientific research and practical therapeutic developments.

Additionally, Dr. Carl June, an esteemed immunotherapy expert from the University of Pennsylvania, will present via video on the advancements in cellular immunotherapies. Dr. Miguel Forte, president of the International Society for Cell and Gene Therapy, will also provide insights regarding clinical translation and scalability challenges, focusing on the journey ahead for CGT.

In-Depth Panel Discussions

The forum's agenda includes four vital panel discussions aimed at addressing core challenges and advancements within CGT:

1. Navigating the Future of Cell Therapy: This session will assess various innovative frameworks in cell therapy, exploring advancements and key challenges related to autologous, allogeneic, and in vivo platforms. Noted figures such as Ying Huang from Legend Biotech and Paul Stoffels from Johnson & Johnson will share their insights.

2. Gene Therapy and mRNA Therapeutics: This panel will delve into how gene and mRNA therapies are tackling the obstacles of delivery and safety. Experts in the field, including Sergio Linares from Sanofi, will discuss translating scientific promise into practice.

3. From Lab to Patient: Overcoming barriers in manufacturing and regulatory compliance is critical for CGT. This discussion, featuring leaders like Jin Yin from ProBio, aims to identify practical solutions to enhance scalability and reproducibility in CGT manufacturing.

4. Innovation and Investment: Exploring how to align cutting-edge innovations with investment strategies will be pivotal for the success of CGT. Investment professionals like Laura Stoppel from RA Capital Management will provide insights on turning breakthroughs into sustainable business models.

Reception and Networking Opportunities

Following the conference, attendees can participate in a reception designed to cultivate meaningful connections among industry professionals, fostering valuable relationships that could further advance the field of cell and gene therapy.

With an agenda packed with expert insights and dialogue, the GenScript Biotech Global Forum is a must-attend event for anyone interested in the future of healthcare. Don't miss this opportunity to be part of the transformative discussions that will shape the next phase of CGT.

Registration Details

Registration for the forum is open, and attendees can secure complimentary tickets. However, spots are limited, so prospective participants should act quickly. For further details and to register, please visit GenScript's website and use the code GSGM3 to claim your complimentary ticket.

Mark your calendars for this pivotal event in one of the fastest-evolving areas of medicine. Together, we can explore and shape the future impact of cell and gene therapies around the globe.